Total Funding
27
Total FundingSeed raised
Growth Score in past quarter
pts
Heat Score 27 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Episona is an epigenetics data company focused on improving healthcare outcomes.
About the Company
Episona's first product, Seed, is an epigenetic test for male infertility focused on decreasing cost and time to pregnancy for those seeking fertility care. Clinically, Seed can identify 1) hidden male factor in cases of unexplained infertility and 2) epigenetic patterns that strongly associate with poor embryogenesis.
Episona is led by an
experienced team of medical doctors and scientists, with world-class expertise in both epigenetics and human reproductive health. The company began operations in 2013 and is headquartered in Pasadena, CA. For more information, visit https://episona.com.

